Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This directory contains data behind the story How Baby Boomers Get High. It covers 13 drugs across 17 age groups.
Source: National Survey on Drug Use and Health from the Substance Abuse and Mental Health Data Archive.
Header | Definition |
---|---|
alcohol-use | Percentage of those in an age group who used alcohol in the past 12 months |
alcohol-frequency | Median number of times a user in an age group used alcohol in the past 12 months |
marijuana-use | Percentage of those in an age group who used marijuana in the past 12 months |
marijuana-frequency | Median number of times a user in an age group used marijuana in the past 12 months |
cocaine-use | Percentage of those in an age group who used cocaine in the past 12 months |
cocaine-frequency | Median number of times a user in an age group used cocaine in the past 12 months |
crack-use | Percentage of those in an age group who used crack in the past 12 months |
crack-frequency | Median number of times a user in an age group used crack in the past 12 months |
heroin-use | Percentage of those in an age group who used heroin in the past 12 months |
heroin-frequency | Median number of times a user in an age group used heroin in the past 12 months |
hallucinogen-use | Percentage of those in an age group who used hallucinogens in the past 12 months |
hallucinogen-frequency | Median number of times a user in an age group used hallucinogens in the past 12 months |
inhalant-use | Percentage of those in an age group who used inhalants in the past 12 months |
inhalant-frequency | Median number of times a user in an age group used inhalants in the past 12 months |
pain-releiver-use | Percentage of those in an age group who used pain relievers in the past 12 months |
pain-releiver-frequency | Median number of times a user in an age group used pain relievers in the past 12 months |
oxycontin-use | Percentage of those in an age group who used oxycontin in the past 12 months |
oxycontin-frequency | Median number of times a user in an age group used oxycontin in the past 12 months |
tranquilizer-use | Percentage of those in an age group who used tranquilizer in the past 12 months |
tranquilizer-frequency | Median number of times a user in an age group used tranquilizer in the past 12 months |
stimulant-use | Percentage of those in an age group who used stimulants in the past 12 months |
stimulant-frequency | Median number of times a user in an age group used stimulants in the past 12 months |
meth-use | Percentage of those in an age group who used meth in the past 12 months |
meth-frequency | Median number of times a user in an age group used meth in the past 12 months |
sedative-use | Percentage of those in an age group who used sedatives in the past 12 months |
sedative-frequency | Median number of times a user in an age group used sedatives in the past 12 months |
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
GUI59 - Respondents aged 25 years who have used cocaine at least once in the last year. Published by Central Statistics Office. Available under the license Creative Commons Attribution 4.0 (CC-BY-4.0).Respondents aged 25 years who have used cocaine at least once in the last year...
EMSIndicators:The number of individual patients administered naloxone by EMSThe number of naloxone administrations by EMSThe rate of EMS calls involving naloxone administrations per 10,000 residentsData Source:The Vermont Statewide Incident Reporting Network (SIREN) is a comprehensive electronic prehospital patient care data collection, analysis, and reporting system. EMS reporting serves several important functions, including legal documentation, quality improvement initiatives, billing, and evaluation of individual and agency performance measures.Law Enforcement Indicators:The Number of law enforcement responses to accidental opioid-related non-fatal overdosesData Source:The Drug Monitoring Initiative (DMI) was established by the Vermont Intelligence Center (VIC) in an effort to combat the opioid epidemic in Vermont. It serves as a repository of drug data for Vermont and manages overdose and seizure databases. Notes:Overdose data provided in this dashboard are derived from multiple sources and should be considered preliminary and therefore subject to change. Overdoses included are those that Vermont law enforcement responded to. Law enforcement personnel do not respond to every overdose, and therefore, the numbers in this report are not representative of all overdoses in the state. The overdoses included are limited to those that are suspected to have been caused, at least in part, by opioids. Inclusion is based on law enforcement's perception and representation in Records Management Systems (RMS). All Vermont law enforcement agencies are represented, with the exception of Norwich Police Department, Hartford Police Department, and Windsor Police Department, due to RMS access. Questions regarding this dataset can be directed to the Vermont Intelligence Center at dps.vicdrugs@vermont.gov.Overdoses Indicators:The number of accidental and undetermined opioid-related deathsThe number of accidental and undetermined opioid-related deaths with cocaine involvementThe percent of accidental and undetermined opioid-related deaths with cocaine involvementThe rate of accidental and undetermined opioid-related deathsThe rate of heroin nonfatal overdose per 10,000 ED visitsThe rate of opioid nonfatal overdose per 10,000 ED visitsThe rate of stimulant nonfatal overdose per 10,000 ED visitsData Source:Vermont requires towns to report all births, marriages, and deaths. These records, particularly birth and death records are used to study and monitor the health of a population. Deaths are reported via the Electronic Death Registration System. Vermont publishes annual Vital Statistics reports.The Electronic Surveillance System for the Early Notification of Community-based Epidemics (ESSENCE) captures and analyzes recent Emergency Department visit data for trends and signals of abnormal activity that may indicate the occurrence of significant public health events.Population Health Indicators:The percent of adolescents in grades 6-8 who used marijuana in the past 30 daysThe percent of adolescents in grades 9-12 who used marijuana in the past 30 daysThe percent of adolescents in grades 9-12 who drank any alcohol in the past 30 daysThe percent of adolescents in grades 9-12 who binge drank in the past 30 daysThe percent of adolescents in grades 9-12 who misused any prescription medications in the past 30 daysThe percent of adults who consumed alcohol in the past 30 daysThe percent of adults who binge drank in the past 30 daysThe percent of adults who used marijuana in the past 30 daysData Sources:The Vermont Youth Risk Behavior Survey (YRBS) is part of a national school-based surveillance system conducted by the Centers for Disease Control and Prevention (CDC). The YRBS monitors health risk behaviors that contribute to the leading causes of death and disability among youth and young adults.The Behavioral Risk Factor Surveillance System (BRFSS) is a telephone survey conducted annually among adults 18 and older. The Vermont BRFSS is completed by the Vermont Department of Health in collaboration with the Centers for Disease Control and Prevention (CDC).Notes:Prevalence estimates and trends for the 2021 Vermont YRBS were likely impacted by significant factors unique to 2021, including the COVID-19 pandemic and the delay of the survey administration period resulting in a younger population completing the survey. Students who participated in the 2021 YRBS may have had a different educational and social experience compared to previous participants. Disruptions, including remote learning, lack of social interactions, and extracurricular activities, are likely reflected in the survey results. As a result, no trend data is included in the 2021 report and caution should be used when interpreting and comparing the 2021 results to other years.The Vermont Department of Health (VDH) seeks to promote destigmatizing and equitable language. While the VDH uses the term "cannabis" to reflect updated terminology, the data sources referenced in this data brief use the term "marijuana" to refer to cannabis. Prescription Drugs Indicators:The average daily MMEThe average day's supplyThe average day's supply for opioid analgesic prescriptionsThe number of prescriptionsThe percent of the population receiving at least one prescriptionThe percent of prescriptionsThe proportion of opioid analgesic prescriptionsThe rate of prescriptions per 100 residentsData Source:The Vermont Prescription Monitoring System (VPMS) is an electronic data system that collects information on Schedule II-IV controlled substance prescriptions dispensed by pharmacies. VPMS proactively safeguards public health and safety while supporting the appropriate use of controlled substances. The program helps healthcare providers improve patient care. VPMS data is also a health statistics tool that is used to monitor statewide trends in the dispensing of prescriptions.Treatment Indicators:The number of times a new substance use disorder is diagnosed (Medicaid recipients index events)The number of times substance use disorder treatment is started within 14 days of diagnosis (Medicaid recipients initiation events)The number of times two or more treatment services are provided within 34 days of starting treatment (Medicaid recipients engagement events)The percent of times substance use disorder treatment is started within 14 days of diagnosis (Medicaid recipients initiation rate)The percent of times two or more treatment services are provided within 34 days of starting treatment (Medicaid recipients engagement rate)The MOUD treatment rate per 10,000 peopleThe number of people who received MOUD treatmentData Source:Vermont Medicaid ClaimsThe Vermont Prescription Monitoring System (VPMS)Substance Abuse Treatment Information System (SATIS)
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
The purpose of this data collection was to investigate the possible increase in gang involvement within cocaine and "rock" cocaine trafficking. Investigators also examined the relationships among gangs, cocaine trafficking, and increasing levels of violence. They attempted to determine the effects of increased gang involvement in cocaine distribution in terms of the location of an incident, the demographic profiles of suspects, and the level of firearm use. They also looked at issues such as whether the connection between gangs and cocaine trafficking yielded more drug-related violence, how the connection between gangs and cocaine trafficking affected police investigative processes such as intra-organizational communication and the use of special enforcement technologies, what kinds of working relationships were established between narcotics units and gang control units, and what the characteristics were of the rock trafficking and rock house technologies of the dealers. Part 1 (Sales Arrest Incident Data File) contains data for the cocaine sales arrest incidents. Part 2 (Single Incident Participant Data File) contains data for participants of the cocaine sales arrest incidents. Part 3 (Single Incident Participant Prior Arrest Data File) contains data for the prior arrests of the participants in the cocaine arrest incidents. Part 4 (Multiple Event Incident Data File) contains data for multiple event incidents. Part 5 (Multiple Event Arrest Incident Data File) contains data for arrest events in the multiple event incidents. Part 6 (Multiple Event Incident Participant Data File) contains data for the participants of the arrest events. Part 7 (Multiple Event Incident Prior Arrest Data File) contains data for the prior arrest history of the multiple event participants. Part 8 (Homicide Incident Data File) contains data for homicide incidents. Part 9 (Homicide Incident Suspect/Victim Data File) contains data for the suspects and victims of the homicide incidents. Major variables characterizing the various units of observation include evidence of gang involvement, presence of drugs, presence of a rock house, presence of firearms or other weapons, presence of violence, amount of cash taken as evidence, prior arrests, and law enforcement techniques.
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about personal and family income sources and amounts, substance abuse treatment history, illegal activities, problems resulting from the use of drugs, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994), were retained in this administration of the survey. Also retained was the section on risk/availability of drugs that was reintroduced in 1996, and sections on driving behavior and personal behavior were added (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996). The 1997 questionnaire (NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1997) introduced new items that the 1998 NHSDA continued on cigar smoking, people who were present when respondents used marijuana or cocaine for the first time (if applicable), reasons for using these two drugs the first time, reasons for using these two drugs in the past year, reasons for discontinuing use of these two drugs (for lifetime but not past-year users), and reasons respondents never used these two drugs. Both the 1997 and 1998 NHSDAs had a series of questions that were asked only of respondents aged 12 to 17. These items covered a variety of topics that may be associated with substance use and related behaviors, such as exposure to substance abuse prevention and education programs, gang involvement, relationship with parents, and substance use by friends. Demographic data include sex, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition. This study has 1 Data Set.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Abstract Introduction: Cocaine is one of the most often used psychoactive drugs worldwide, being extracted from the leaves of Erytroxylus coca plant. Its abusive use can trigger several consequences for the human body, including the oral cavity. Objective: To identify the oral disorders that are most commonly found in individuals who abuse cocaine, in addition to the main diagnostic and treatment methods. Methods: An integrative review was carried out on the databases: LILACS, BBO, LIS, MEDLINE, SciELO, Science Direct and PubMed. The following keywords were used: ‟Cocaína”, ‟Boca”, ‟Palato” and ‟Odontologia”, together with their synonyms and variations in English, obtained from DeCS andMeSH. The inclusion criteria were original articles, articles in Portuguese, English and Spanish, studies involving individuals, without restriction related to the year of publication. Animal studies, literature reviews, book chapters, theses and dissertations were excluded. Results: In total, 1373 records were identified. Of these, 22 articles were selected to comprise the review. Several oral alterations caused by cocaine abuse were found, primarily perforation of the palate, predisposition to periodontal diseases, temporomandibular disorders, bruxism, damage to oral tissues, dental caries, destructive lesions of the facial midline, xerostomia and ageusia. Among the diagnostic methods used by the professionals, anamnesis, intraoral examinations and head and neck computed tomography were the most frequently mentioned. As for treatment, in patients with palatal perforation, the reconstruction of the affected area or the use of prosthetic obturators is carried out. Conclusion: The management of these patients is not an easy task, as many of the users do not even seek professional help. The health professionals must be able to recognize these manifestations and alterations to establish timely and accurate diagnosis and treatment planning. © 2021 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/). HIGHLIGHTS Integrative review aiming to detect oral changes in cocaine abusers. The main oral changes, methods of diagnosis and treatment were identified. Good anamnesis and qualified health professionals are necessary.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Raw data on drug consumption levels monitored by wastewater analysis. Sampling occurs every two months. Consumption levels are expressed in doses in the accompanying report for Stimulants (cocaine, MDMA and methamphetamine), Opioids (morphine, codeine, methadone, oxycodone, fentanyl and heroin), Cannabis (THC), and Nicotine. Anabasine (a tobacco-specific alkaloid that allows us to differentiate between cigarettes and other nicotine-containing products such as patches, e-cigarettes, etc) consumption levels are expressed in number of cigarettes. Alcohol consumption levels are expressed as standard drinks. Bi-monthly reports of these data can be found on the SA Health website.
https://www.icpsr.umich.edu/web/ICPSR/studies/36937/termshttps://www.icpsr.umich.edu/web/ICPSR/studies/36937/terms
This data collection is part of the Monitoring the Future series that explores changes in important values, behaviors, and lifestyle orientations of contemporary American youth in eighth, tenth, and twelfth grades. The collection provides two datasets for each year since 1976 that are accessible only through the ICPSR Virtual Data Enclave VDE) and include original variables, including the unaltered weight variable, that in the public-use data were altered or omitted: one dataset without State, County, and Zip Code and one dataset including State, County, and Zip Code. Use of the geographic identifiers such as state, county, or zip code is limited and researchers interested in these variables are encouraged to read FAQs: About MTF Restricted-Use Geographic and Other Variables. Also included as part of each annual collection is a zip archive of the Monitoring the Future public-use data and documentation for each respective year. The basic research design used by the Monitoring the Future study involves annual data collections from eighth, tenth, and twelfth graders throughout the coterminous United States during the spring of each year. The 8th/10th grade surveys used four different questionnaire forms (and only two forms from 1991-1996) rather than the six used with seniors. Identical forms are used for both eighth and tenth grades, and for the most part, questionnaire content is drawn from the twelfth-grade questionnaires. Thus, key demographic variables and measures of drug use and related attitudes and beliefs are generally identical for all three grades. However, many fewer questions about lifestyles and values are included in the 8th/10th grade forms. Drugs covered by this survey include tobacco, smokeless tobacco, alcohol, marijuana, hashish, prescription medications, over-the-counter medications, inhalants, steroids, LSD, hallucinogens, amphetamines (stimulants), Ritalin (methylphenidate), Quaaludes (methaqualone), barbiturates (tranquilizers), cocaine, crack cocaine, ecstasy, methamphetamine, heroin, and GHB (gamma hydroxy butyrate). Other topics include attitudes toward religion, changing roles for women, educational aspirations, self-esteem, exposure to drug education, and violence and crime (both in and out of school).
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Annual number of deaths registered related to drug poisoning, by local authority, England and Wales.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
BackgroundPeripheral artery disease (PAD) is on the rise worldwide, ranking as the third leading cause of atherosclerosis-related morbidity; much less is known about its trends in hospitalizations among methamphetamine and cocaine users.ObjectivesWe aim to evaluate the overall trend in the prevalence of hospital admission for PAD with or without the use of stimulant abuse (methamphetamine and cocaine) across the United States. Additionally, we evaluated the PAD-related hospitalizations trend stratified by age, race, sex, and geographic location.MethodsWe used the National Inpatient Sample (NIS) database from 2008 to 2020. The Cochran Armitage trend test was used to compare the trend between groups. Multivariate logistic regression was used to examine adjusted odds for PAD and CLI hospitalizations among methamphetamine and cocaine users.ResultsBetween 2008 and 2020, PAD-related hospitalizations showed an increasing trend in Hispanics, African Americans, and western states, while a decreasing trend in southern and Midwestern states (p-trend 40, and all regions (p-trend
The primary objective of the National Pregnancy and Health
Survey (NPHS) was to produce national annual estimates of the
percentages and numbers of mothers of live newborns in the United
States who used selected licit and illicit drugs in the 12 months
prior to delivery. A further objective was to describe patterns of
prenatal substance use among demographic subgroups of
women. Information on demographic and socioeconomic characteristics,
obstetric history, and drug treatment of women who delivered infants
at sampled hospitals was obtained through an interviewer-administered
questionnaire, while data on substance use before and during pregnancy
were collected through a questionnaire completed by the respondent and
concealed from the interviewer. Respondents were asked about use of
the following substances: alcohol, amphetamines, analgesics, cocaine,
crack cocaine, barbiturates, hallucinogens, hashish, heroin,
marijuana, methadone, methamphetamine, sedatives, stimulants, tobacco,
and tranquilizers. Additionally, information was collected on the
respondent's pregnancy, prenatal care, delivery, previous pregnancies,
and background. Additional data were obtained from the mothers' and
infants' medical records. Urine specimens collected routinely by the
hospital on obstetric admissions were tested for selected
drugs. Finally, in a subsample of six hospitals, hair specimens were
requested from respondents to evaluate the potential of hair as a
source of toxicological data in future studies.This study has 1 Data Set.
This study was undertaken to measure the impact of the standard, treatment, and sanction dockets, which comprise the Superior Court Drug Intervention Program (SCDIP), on drug-involved defendants in Washington, DC, while examining defendants' continued drug use and substance abuse, criminal activity, and social and economic functioning. Features common to all three dockets of the SCDIP program included early intervention, frequent drug testing, and judicial involvement in monitoring drug test results, as well as the monitoring of each defendant's progress. Data for this study were collected from four sources for defendants arrested on drug felony charges between September 1, 1994, and January 31, 1996, who had been randomly assigned to one of three drug dockets (sanction, treatment, or standard) as part of the SCDIP program. First, data were collected from the Pretrial Services Agency, which provided monthly updated drug testing records, case records, and various other administrative records for all defendants assigned to any of the three dockets. Second, data regarding prior convictions and sentencing information were collected from computer files maintained by the Washington, DC, Superior Court. Third, arrest data were taken from the Uniform Crime Reporting Program. Lastly, data on self-reported drug use, criminal and personal activities, and opinions about the program were collected from interviews conducted with defendants one year after their sentencing. Variables collected from administrative records included drug test results, eligibility date for the defendant, date the defendant started treatment, number of compliance hearings, prior conviction, arrest, and sentencing information, and program entry date. Survey questions asked of each respondent fell into one of seven categories: (1) Individual characteristics, such as gender, age, and marital status. (2) Current offenses, including whether the respondent was sentenced to probation, prison, jail, or another correctional facility for any offense and the length of sentencing, special conditions or restrictions of that sentence (e.g., electronic monitoring, mandatory drug testing, educational programs, or psychological counseling), whether any of the sentence was reduced by credit, and whether the respondent was released on bail bond or to the custody of another person. (3) Current supervision, specifically, whether the respondent was currently on probation, the number and type of contacts made with probation officers, issues discussed during the meeting, any new offenses or convictions since being on probation, outcome of any hearings, and reasons for returning back to prison, jail, or another correctional facility. (4) Criminal history, such as the number of previous arrests, age at first arrest, sentencing type, whether the respondent was a juvenile, a youthful offender, or an adult when the crime was committed, and whether any time was served for each of the following crimes: drug trafficking, drug possession, driving while intoxicated, weapons violations, robbery, sexual assault/rape, murder, other violent offenses, burglary, larceny/auto theft, fraud, property offenses, public order offenses, and probation/parole violations. (5) Socioeconomic characteristics, such as whether the respondent had a job or business, worked part- or full-time, type of job or business, yearly income, whether the respondent was looking for work, the reasons why the respondent was not looking for work, whether the respondent was living in a house, apartment, trailer, hotel, shelter, or other type of housing, whether the respondent contributed money toward rent or mortgage, number of times moved, if anyone was living with the respondent, the number and ages of any children (including step or adopted), whether child support was being paid by the respondent, who the respondent lived with when growing up, the number of siblings the respondent had, whether any of the respondent's parents spent any time in jail or prison, and whether the respondent was ever physically or sexually abused. (6) Alcohol and drug use and treatment, specifically, the type of drug used (marijuana, crack cocaine, other cocaine, heroin, PCP, and LSD), whether alcohol was consumed, the amount of each that was typically used/consumed, and whether any rehabilitation programs were attended. (7) Other services, programs, and probation conditions, such as whether any services were received for emotional or mental health problems, if any medications were prescribed, and whether the respondent was required to participate in a mental health services program, vocational training program, educational program, or community service program.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This directory contains data behind the story How Baby Boomers Get High. It covers 13 drugs across 17 age groups.
Source: National Survey on Drug Use and Health from the Substance Abuse and Mental Health Data Archive.
Header | Definition |
---|---|
alcohol-use | Percentage of those in an age group who used alcohol in the past 12 months |
alcohol-frequency | Median number of times a user in an age group used alcohol in the past 12 months |
marijuana-use | Percentage of those in an age group who used marijuana in the past 12 months |
marijuana-frequency | Median number of times a user in an age group used marijuana in the past 12 months |
cocaine-use | Percentage of those in an age group who used cocaine in the past 12 months |
cocaine-frequency | Median number of times a user in an age group used cocaine in the past 12 months |
crack-use | Percentage of those in an age group who used crack in the past 12 months |
crack-frequency | Median number of times a user in an age group used crack in the past 12 months |
heroin-use | Percentage of those in an age group who used heroin in the past 12 months |
heroin-frequency | Median number of times a user in an age group used heroin in the past 12 months |
hallucinogen-use | Percentage of those in an age group who used hallucinogens in the past 12 months |
hallucinogen-frequency | Median number of times a user in an age group used hallucinogens in the past 12 months |
inhalant-use | Percentage of those in an age group who used inhalants in the past 12 months |
inhalant-frequency | Median number of times a user in an age group used inhalants in the past 12 months |
pain-releiver-use | Percentage of those in an age group who used pain relievers in the past 12 months |
pain-releiver-frequency | Median number of times a user in an age group used pain relievers in the past 12 months |
oxycontin-use | Percentage of those in an age group who used oxycontin in the past 12 months |
oxycontin-frequency | Median number of times a user in an age group used oxycontin in the past 12 months |
tranquilizer-use | Percentage of those in an age group who used tranquilizer in the past 12 months |
tranquilizer-frequency | Median number of times a user in an age group used tranquilizer in the past 12 months |
stimulant-use | Percentage of those in an age group who used stimulants in the past 12 months |
stimulant-frequency | Median number of times a user in an age group used stimulants in the past 12 months |
meth-use | Percentage of those in an age group who used meth in the past 12 months |
meth-frequency | Median number of times a user in an age group used meth in the past 12 months |
sedative-use | Percentage of those in an age group who used sedatives in the past 12 months |
sedative-frequency | Median number of times a user in an age group used sedatives in the past 12 months |